Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 STADA Licenses Transdermal Patch from 3M DDS | Contract Pharma

What are you searching for?

Sign in
Breaking News

STADA Licenses Transdermal Patch from 3M DDS

To deliver opioid pain medication fentanyl

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

STADA Arzneimittel AG has licensed 3M Drug Delivery Systems’ transdermal patch technology for the transdermal delivery of the opioid pain medication fentanyl. Terms of the agreement were not disclosed. 
 
The 3M Patent (EP 2158905) was granted on March 20, 2013 and enables the transdermal drug delivery of a therapeutically effective amount of fentanyl across the skin of a patient. The matrix device incorporates fentanyl into an adhesive matrix made of a copolymer containing alkyl acrylate and other monomers.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics